Aurinia Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts that cover Aurinia Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $17.25, which forecasts a 7.95% increase in the stock price over the next year. The lowest target is $15 and the highest is $21.

Price Target: $17.25 (+7.95%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$15	$17.25	$17	$21
Change	-6.13%	+7.95%	+6.38%	+31.41%

* Price targets were last updated on Dec 3, 2025.

Analyst Ratings

The average analyst rating for Aurinia Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	1	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Schwartz Leerink Partners	Leerink Partners	Buy → Hold Downgrades $15 → $16	Buy → Hold	Downgrades	$15 → $16	+0.13%	Dec 3, 2025
Maury Raycroft Jefferies	Jefferies	Hold → Strong Buy Upgrades $10 → $21	Hold → Strong Buy	Upgrades	$10 → $21	+31.41%	Nov 7, 2025
Douglas Miehm RBC Capital	RBC Capital	Buy → Hold Downgrades $9 → $15	Buy → Hold	Downgrades	$9 → $15	-6.13%	Nov 5, 2025
Douglas Miehm RBC Capital	RBC Capital	Buy Maintains $8 → $9	Buy	Maintains	$8 → $9	-43.68%	Aug 1, 2025
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $17	Strong Buy	Initiates	$17	+6.38%	Jul 30, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

332.71M

from 283.06M

17.54%

from 283.06M

Revenue Next Year

385.09M

from 332.71M

15.74%

from 332.71M

EPS This Year

0.81

from 2.07

-60.97%

from 2.07

EPS Next Year

1.07

from 0.81

32.32%

from 0.81

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	45.61M	134.03M	175.51M	235.13M	283.06M	332.71M	385.09M
Revenue Growth	-9.01%	193.89%	30.95%	33.97%	20.38%	17.54%	15.74%
EPS	-1.40	-0.76	-0.54	0.04	2.07	0.81	1.07
EPS Growth	-	-	-	-	5,075.00%	-60.97%	32.32%
Forward PE	-	-	-	-	-	19.78	14.95
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	360.7M	478.2M
Avg	332.7M	385.1M
Low	313.6M	352.8M

Revenue Growth

Revenue Growth	2026	2027
High	27.4%	43.7%
Avg	17.5%	15.7%
Low	10.8%	6.0%

EPS Forecast

EPS	2026	2027
High	0.98	1.65
Avg	0.81	1.07
Low	0.67	0.55

EPS Growth

EPS Growth	2026	2027
High	-52.8%	104.1%
Avg	-61.0%	32.3%
Low	-67.8%	-32.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.